|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/565 | (2006.01) |
| A61K 9/0053 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/565 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 3661520 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18705663.5 |
| Date of filing the European patent application | 2018-02-23 | |
| (97) | Date of publication of the European application | 2020-06-10 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/054470 |
| Date | 2018-02-23 |
| (87) | Number | WO 2019/025031 |
| Date | 2019-02-07 |
| (30) | Number | Date | Country code |
| 17184320 | 2017-08-01 | EP |
| (72) |
DEBRUYNE, F.M.J. , NL
|
| (73) |
Fund SA ,
Rue Saint Georges 5, 4000 Liège,
BE
|
| (54) | ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT |
| ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT |